Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in Singapore

References

• VaronEMainardiJLGutmannLStreptococcus pneumoniae: still a major pathogenClin Microbiol Infect201016540120394638
   PubMed Web of Science ®Google Scholar
• FeldmanCAndersonRBacteraemic pneumococcal pneumonia: current therapeutic optionsDrugs201171213115321275443
   PubMed Web of Science ®Google Scholar
• van der PollTOpalSMPathogenesis, treatment, and prevention of pneumococcal pneumoniaLancet200937497001543155619880020
   PubMed Web of Science ®Google Scholar
• Vila-CorcolesAOchoa-GondarORodriguez-BlancoTRaga-LuriaXGomez-BertomeuFEpidemiology of community-acquired pneumonia in older adults: a population-based studyRespir Med2009103230931618804355
   PubMed Web of Science ®Google Scholar
• JacobsMRAntimicrobial-resistant Streptococcus pneumoniae: trends and managementExpert Rev Anti Infect Ther20086561963518847402
   PubMed Web of Science ®Google Scholar
• EkdahlKAhlinderIHanssonHBDuration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention ProjectClin Infect Dis1997255111311179402367
   PubMed Web of Science ®Google Scholar
• LeinoTAuranenKJokinenJLeinonenMTervonenPTakalaAKPneumococcal carriage in children during their first two years: important role of family exposurePediatr Infect Dis J200120111022102711734705
   PubMed Web of Science ®Google Scholar
• LingMLTayLEpidemiology of pneumococcal infection in Singapore (1977–1986)Ann Acad Med Singapore19901967777802130739
   PubMedGoogle Scholar
• ChongCYKoh-ChengTYee-HuiMNancyTWInvasive pneumococcal disease in Singapore childrenVaccine20082627–283427343118499309
   PubMed Web of Science ®Google Scholar
• DaganRPattersonSJuergensCComparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trialClin Infect Dis201357795296223804191
   PubMed Web of Science ®Google Scholar
• VasooSSinghKHsuLYIncreasing antibiotic resistance in Streptococcus pneumoniae colonizing children attending day-care centres in SingaporeRespirology20111681241124821848708
   PubMed Web of Science ®Google Scholar
• Ministry of Health, SingaporePneumococcal serotyping for surveillance of invasive pneumococcal diseases in Singapore, 2010–2011Epidemiological News Bulletin20123622935
   Google Scholar
• Ministry of Health, SingaporeLaboratory data on surveillance of invasive pneumococcal diseases in Singapore, 2012Epidemiological News Bulletin20133923439
   Google Scholar
• AlibertiSAmirAPeyraniPIncidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumoniaChest2008134595596218583514
   PubMed Web of Science ®Google Scholar
• Corrales-MedinaVFMusherDMWellsGAChirinosJAChenLFineMJCardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortalityCirculation2012125677378122219349
   PubMed Web of Science ®Google Scholar
• Corrales-MedinaVFMusherDMShachkinaSChirinosJAAcute pneumonia and the cardiovascular systemLancet2013381986549650523332146
   PubMed Web of Science ®Google Scholar
• MarrieTJShariatzadehMRCommunity-acquired pneumonia requiring admission to an intensive care unit: a descriptive studyMedicine (Baltimore)200786210311117435590
   PubMed Web of Science ®Google Scholar
• Principal causes of death [webpage on the Internet]SingaporeMinistry of Health2012 [cited December 14, 2012]. Available from: http://www.moh.gov.sg/content/moh_web/home/statistics/Health_Facts_Singapore/Principal_Causes_of_Death.htmlAccessed September 3, 2013
   Google Scholar
• FungHBMonteagudo-ChuMOCommunity-acquired pneumonia in the elderlyAm J Geriatr Pharmacother201081476220226392
   PubMedGoogle Scholar
• JacksonMLNeuzilKMThompsonWWThe burden of community-acquired pneumonia in seniors: results of a population-based studyClin Infect Dis200439111642165015578365
   PubMed Web of Science ®Google Scholar
• FineMJSmithMACarsonCAPrognosis and outcomes of patients with community-acquired pneumonia. A meta-analysisJAMA199627521341418531309
   PubMed Web of Science ®Google Scholar
• BartlettJTreatment of community-acquired pneumoniaChemotherapy200046Suppl 1243110810210
   PubMed Web of Science ®Google Scholar
• World Health OrganizationPneumococcal conjugate vaccine for childhood immunization – WHO position paperWkly Epidemiol Rec200782129310417380597
   PubMedGoogle Scholar
• Centers for Disease Control and PreventionActive Bacterial Core Surveillance Report Emerging Infections Program Network: Group A Streptococcus, 2011Atlanta, GACenters for Disease Control and Prevention2012 Available from: http://www.cdc.gov/abcs/reports-findings/survreports/gas11.pdfAccessed September 3, 2013
   Google Scholar
• List of infectious diseases legally notifiable under the Infectious Diseases Act [webpage on the Internet]SingaporeMinistry of Health2010 Available from: http://www.moh.gov.sg/content/moh_web/moh_corp_mobile/home/diseases_conditions/List_of_Infectious_Diseases_Legally_Notifiable_under_the_Infectious_Diseases_Act.htmlAccessed September 3, 2013
   Google Scholar
• LowSChanFLCutterJMaSGohKTChewSKA national study of the epidemiology of pneumococcal disease among hospitalised patients in Singapore: 1995 to 2004Singapore Med J200748982482917728963
   PubMedGoogle Scholar
• HsuLYLuiSWLeeJLAdult invasive pneumococcal disease pre- and peri-pneumococcal conjugate vaccine introduction in a tertiary hospital in SingaporeJ Med Microbiol200958Pt 110110419074659
   PubMed Web of Science ®Google Scholar
• SongJHChangHHSuhJYMacrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)J Antimicrob Chemother200453345746314963068
   PubMed Web of Science ®Google Scholar
• WeinsteinMPKlugmanKPJonesRNRationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistanceClin Infect Dis200948111596160019400744
   PubMed Web of Science ®Google Scholar
• LynchJP3rdZhanelGGStreptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccinesCurr Opin Pulm Med201016321722520375783
   PubMed Web of Science ®Google Scholar
• FedsonDSGuppyMJPneumococcal vaccination of older adults: conjugate or polysaccharide?Hum Vaccin Immunother2013961382138423732892
   PubMed Web of Science ®Google Scholar
• FedsonDSMusherDMPneumococcal polysaccharide vaccinePlotkinSAOrensteinWAOffitPAVaccines4th edPhiladelphia, PAWB Saunders and Company2004529588
   Google Scholar
• DaganRGivon-LaviNZamirOReduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centersJ Infect Dis2002185792793611920317
   PubMed Web of Science ®Google Scholar
• FletcherMALauferDSMcIntoshEDCiminoCMalinoskiFJControlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?Int J Clin Pract200660445045616620359
   PubMed Web of Science ®Google Scholar
• CohenRLevyCBingenEKoskasMNaveIVaronEImpact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis mediaPediatr Infect Dis J201231329730122330166
   PubMed Web of Science ®Google Scholar
• MusherDMEditorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults?Clin Infect Dis201255226526722495544
   PubMed Web of Science ®Google Scholar
• AndrewsNJWaightPAGeorgeRCSlackMPMillerEImpact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and WalesVaccine201230486802680823000122
   PubMed Web of Science ®Google Scholar
• Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Recomm Rep199746RR-8124
   Google Scholar
• TalbotTRHartertTVMitchelEAsthma as a risk factor for invasive pneumococcal diseaseN Engl J Med2005352202082209015901861
   PubMed Web of Science ®Google Scholar
• NuortiJPButlerJCFarleyMMCigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance TeamN Engl J Med20003421068168910706897
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionAdvisory Committee on Immunization PracticesUpdated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23)MMWR Morb Mortal Wkly Rep201059341102110620814406
   PubMedGoogle Scholar
• BadertscherNMorellSRosemannTTandjungRGeneral practitioners’ experiences, attitudes, and opinions regarding the pneumococcal vaccination for adults: a qualitative studyInt J Gen Med2012596797423204861
   PubMedGoogle Scholar
• ParadisoPRPneumococcal conjugate vaccine for adults: a new paradigmClin Infect Dis201255225926422495545
   PubMed Web of Science ®Google Scholar
• RichmondPBorrowRMillerEMeningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memoryJ Infect Dis199917961569157210228085
   PubMed Web of Science ®Google Scholar
• TorlingJHedlundJKonradsenHBOrtqvistARevaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumoniaVaccine20032219610314604576
   PubMed Web of Science ®Google Scholar
• BlackSShinefieldHFiremanBEfficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center GroupPediatr Infect Dis J200019318719510749457
   PubMed Web of Science ®Google Scholar
• MillarEVWattJPBronsdonMAIndirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household membersClin Infect Dis200847898999618781875
   PubMed Web of Science ®Google Scholar
• WhitneyCGFarleyMMHadlerJDecline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccineN Engl J Med2003348181737174612724479
   PubMed Web of Science ®Google Scholar
• FrenchNGordonSBMwalukomoTA trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adultsN Engl J Med2010362981282220200385
   PubMed Web of Science ®Google Scholar
• DransfieldMTNahmMHHanMKSuperior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180649950519556517
   PubMed Web of Science ®Google Scholar
• DugganSTPneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) (Prevenar 13®)Drugs201070151973198620883054
   PubMed Web of Science ®Google Scholar
• KieningerDMKueperKSteulKSafety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in GermanyVaccine201028254192420320417262
   PubMed Web of Science ®Google Scholar
• PloskerGL13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescentsPaediatr Drugs201315540342324030738
   PubMed Web of Science ®Google Scholar
• SchwarzTFFlamaingJRumkeHCA randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 yearsVaccine201129325195520221619909
   PubMed Web of Science ®Google Scholar
• PaviaMBiancoANobileCGMarinelliPAngelilloIFEfficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysisPediatrics20091236e1103e111019482744
   PubMed Web of Science ®Google Scholar
• MoberleySAHoldenJTathamDPAndrewsRMVaccines for preventing pneumococcal infection in adults [review]Cochrane Database Syst Rev20081CD00042218253977
   PubMed Web of Science ®Google Scholar
• World Health Organization23-valent pneumococcal polysaccharide vaccine. WHO position paperWkly Epidemiol Rec2008834237338418927997
   PubMedGoogle Scholar
• FrenchNNakiyingiJCarpenterLM23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trialLancet200035592212106211110902624
   PubMed Web of Science ®Google Scholar
• MeterskyMLDransfieldMTJacksonLADetermining the optimal pneumococcal vaccination strategy for adults: is there a role for the pneumococcal conjugate vaccine?Chest2010138348649020576729
   PubMed Web of Science ®Google Scholar
• Romero-SteinerSMusherDMCetronMSReduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidityClin Infect Dis199929228128810476727
   PubMed Web of Science ®Google Scholar
• Romero-SteinerSLibuttiDPaisLBStandardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cellsClin Diagn Lab Immunol1997444154229220157
   PubMedGoogle Scholar
• SchuermanLPrymulaRHenckaertsIPoolmanJELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis mediaVaccine200725111962196817258357
   PubMed Web of Science ®Google Scholar
• JacksonLAGurtmanAvan CleeffMImmunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adultsVaccine201331353577358423688526
   PubMed Web of Science ®Google Scholar
• JacksonLAGurtmanAvan CleeffMInfluence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and olderVaccine201331353594360223688525
   PubMed Web of Science ®Google Scholar
• JacksonLAGurtmanARiceKImmunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccineVaccine201331353585359323688527
   PubMed Web of Science ®Google Scholar
• HakEGrobbeeDESandersEARationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adultsNeth J Med200866937838318990781
   PubMed Web of Science ®Google Scholar
• PfizerPfizer completes pneumococcal pneumonia case accrual for CAPiTA, adult vaccine clinical trial of Prevenar 13* [press release]New York, NYPfizer2013829 Available from: http://press.pfizer.com/press-release/pfizer-completes-pneumococcal-pneumonia-case-accrual-capita-adult-vaccine-clinical-triAccessed September 3, 2013
   Google Scholar
• PilishviliTLexauCFarleyMMSustained reductions in invasive pneumococcal disease in the era of conjugate vaccineJ Infect Dis20102011324119947881
   PubMed Web of Science ®Google Scholar
• ClemensJShinSAliMNew approaches to the assessment of vaccine herd protection in clinical trialsLancet Infect Dis201111648248721616458
   PubMed Web of Science ®Google Scholar
• PaulYHerd immunity and herd protectionVaccine2004223–430130214670308
   PubMed Web of Science ®Google Scholar
• FinePEamesKHeymannDL“Herd immunity”: a rough guideClin Infect Dis201152791191621427399
   PubMed Web of Science ®Google Scholar
• KyawMHRoseCEJrFryAMThe influence of chronic illnesses on the incidence of invasive pneumococcal disease in adultsJ Infect Dis2005192337738615995950
   PubMed Web of Science ®Google Scholar
• CohenALHarrisonLHFarleyMMPrevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunizationAIDS201024142253226220671543
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC)Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Morb Mortal Wkly Rep2012614081681923051612
   PubMedGoogle Scholar
• HannaJNHumphreysJLMurphyDMSmithHVInvasive pneumococcal disease in non-indigenous people in north Queensland, 2001–2009Med J Aust2010193739239620919968
   PubMed Web of Science ®Google Scholar
• MillerEAndrewsNJWaightPASlackMPGeorgeRCHerd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort studyLancet Infect Dis2011111076076821621466
   PubMed Web of Science ®Google Scholar
• ArdanuyCTubauFPallaresREpidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997–2007Clin Infect Dis2009481576419035779
   PubMed Web of Science ®Google Scholar
• FenollAGranizoJJAguilarLTemporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007J Clin Microbiol20094741012102019225097
   PubMed Web of Science ®Google Scholar
• LepoutreAVaronEGeorgesSGutmannLLevy-BruhlDImpact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001–2006Euro Surveill20081335pii18962
   Google Scholar
• HanquetGKisslingEFenollAPneumococcal serotypes in children in four European countriesEmerg Infect Dis20101691428143920735928
   PubMed Web of Science ®Google Scholar
• RozenbaumMHHoekAJHakEPostmaMJHuge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar)Vaccine201028122367236920085833
   PubMed Web of Science ®Google Scholar
• TyoKRRosenMMZengWCost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccinesVaccine201129386686669421745516
   PubMed Web of Science ®Google Scholar
• ACIP Adult Immunization Work GroupBridgesCBWoodsLCoyne-BeasleyTCenters for Disease Control and Prevention (CDC)Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older – United States, 2013MMWR Surveill Summ201362Suppl 191923364303
   PubMed Web of Science ®Google Scholar
• Committee for Medicinal Products for Human Use (CHMP)Summary of Opinion: Prevenar 13LondonEuropean Medicines Agency2013 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion/human/001104/WC500143813.pdfAccessed September 3, 2013
   Google Scholar
• SunHKNicolauDPKutiJLResource utilization of adults admitted to a large urban hospital with community-acquired pneumonia caused by Streptococcus pneumoniaeChest2006130380781416963679
   PubMed Web of Science ®Google Scholar
• LeeKKRinaldiFChanMKEconomic evaluation of universal infant vaccination with 7vPCV in Hong KongValue Health200912Suppl 3S42S4820586981
   PubMed Web of Science ®Google Scholar
• SohnHSSuhDCJangEKwonJWEconomic evaluation of childhood 7-valent pneumococcal conjugate vaccination in KoreaJ Manag Care Pharm2010161324520044845
   PubMed Web of Science ®Google Scholar
• RubinJLMcGarryLJStruttonDRPublic health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United StatesVaccine201028487634764320883739
   PubMed Web of Science ®Google Scholar
• SmithKJWateskaARNowalkMPRaymundMNuortiJPZimmermanRKCost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccineJAMA2012307880481222357831
   PubMed Web of Science ®Google Scholar
• SmithKJNowalkMPRaymundMZimmermanRKCost- effectiveness of pneumococcal conjugate vaccination in immunocompromised adultsVaccine201331373950395623806240
   PubMed Web of Science ®Google Scholar
• LianLPBridging the gap: the PDV programme at Tan Tock Seng Hospital [abstract]Ann Acad Med Singapore201140Suppl 7S4
   Google Scholar
• Centers for Disease Control and PreventionAdult vaccination coverage – United States, 2010MMWR Morb Mortal Wkly Rep2012614667222298302
   PubMedGoogle Scholar
• Adult immunization: shots to save lives [webpage on the internet]Washington, DCTrust for America’s Health2010 Available from: http://healthyamericans.org/report/73/adultimmunization-2010Accessed September 3, 2013
   Google Scholar
• Centers for Disease Control and PreventionPneumococcal diseaseAtkinsonWWolfeSHamborskyJEpidemiology and Prevention of Vaccine-Preventable Diseases12th edWashington, DCPublic Health Foundation2012233248
   Google Scholar
• NowalkMPNolanBANutiniJSuccess of the 4 Pillars Toolkit for influenza and pneumococcal vaccination in adultsJ Healthc Qual Epub6182013
   Web of Science ®Google Scholar
• MiddletonDBLinCJSmithKJEconomic evaluation of standing order programs for pneumococcal vaccination of hospitalized elderly patientsInfect Control Hosp Epidemiol200829538539418521990
   PubMed Web of Science ®Google Scholar